Evaluating a new eye shield for post-operative cataract care
The Utility of a Novel Eye Shield With Reusable Adhesive Anchors for Post-operative Care After Ophthalmic Surgery
This study is testing a new eye shield for patients recovering from cataract surgery to see if it works better and makes them happier than the standard eye shield.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Augusta University Academic / other |
| Locations | 1 site (Augusta, Georgia) |
| Trial ID | NCT05957796 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness and patient satisfaction of a novel eye shield designed with reusable adhesive anchors compared to the standard Alcon plastic eye shield after cataract surgery. A total of 20 patients will be randomly assigned to receive either the new eye shield or the standard one following their cataract extraction and intraocular lens placement. The study will focus on patient preference and compliance with postoperative care instructions. The goal is to determine if the new eye shield can enhance the postoperative experience for patients undergoing cataract surgery.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older scheduled for cataract surgery with plans for sequential surgeries within three months.
Not a fit: Patients undergoing more complex intraocular surgeries or those who are pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient satisfaction and compliance in postoperative care after cataract surgery.
How similar studies have performed: While similar studies on postoperative care exist, this specific approach with a novel adhesive mechanism is relatively untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or Female cataract surgery patients of 18 years or older, with surgical plans for cataract extraction via phacoemulsification and intraocular lens placement. Patient must be having plans to have both eye cataracts removed surgically in succession within 3 months of each other. Exclusion Criteria: * Patients receiving more advanced intraocular surgery, even if that surgery includes cataract removal and intraocular lens placement, including trabeculectomy, microinvasive glaucoma surgery, vitrectomy, or any other ophthalmic procedure. Pregnancy also an exclusion criteria.
Where this trial is running
Augusta, Georgia
- Augusta University — Augusta, Georgia, United States (Recruiting)
Study contacts
- Study coordinator: Daniel Farrell, MD
- Email: dafarrell@augusta.edu
- Phone: (706) 721-2020
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.